Approximately 280 million people in the world suffer for depression. Despite this, the disorder remains poorly explained and is often difficult to treat. Ketamine could offer an innovative approach.
Academic rigor, journalistic flair
Articles on Ketamine
Displaying all articles
What happens when drug testing experts come across a substance they have never seen before?
In a new study, a single infusion of the antidepressant – along with repeated exposure to positive imagery – significantly reduced symptoms in depressed patients in a clinical trial.
Now restrictions are easing, some people who have not used alcohol or other drugs recently may start to use them again, and need to be aware of their reduced tolerance.
Preventing drink spiking is a collective responsibility, not something to be shouldered by potential victims.
Drugs like ketamine can relieve depression symptoms, including suicidal thoughts, within hours, but they also carry risks that patients need to understand.
This brain region also shows how effective certain treatments will be.
Drugs like MDMA, ketamine, LSD and psylocibin may help heal the wounds of trauma - but more research is needed.
Ketamine and other psychedelics are being licensed for medical use – two experts advise how to minimise harm for users.
Research shows that ketamine can produce long-term reductions in symptoms of treatment-resistant depression.
A safety committee convened by the FDA has declared esketamine safe for severe depression. But isn’t this drug the same as ketamine, an illegal street drug? A medical anthropologist explains.
We’ve got better at managing the health risks of traditional drugs of abuse, but novel psychoactive substances, or ‘legal highs’, are a dangerous unknown.
Psychedelic drugs have inspired great songs and works of art. But they may also have potential for treating disease like depression and PTSD by helping to regrow damaged regions of the brain.
A new study among gay and bisexual men living with HIV found those who were occasional or regular users of party drugs reported significantly better social outcomes than non-users.
At higher doses ketamine is used to induce a trance-like state, sedate people with burns or other traumatic injuries, or as an anaesthetic to perform short operations.
During the 1950s and 1960s, LSD was used more for psychotherapy than recreation. Between 1950 and 1965, many were treated with LSD for alcoholism, depression, schizophrenia, autism and homosexuality.
Ketamine may be the latest recreational drug to find a new legal use.
Ketamine may play a role in preventing suicide and lifting the mood of severely depressed patients, according to a new study…
The close of 2013 saw a drugs bust of cinematic proportions in China. Part of Operation Thunder, more than 3,000 armed police with a cavalry of helicopters, motorboats and police dogs busted the village…
Sometimes it seems you’ve only got to turn around and there is another drug in the news. Now we are told that ketamine should be upgraded from being a Class C drug to a Class B drug. Why does this matter…
Top contributors
-
Professor at the National Drug Research Institute (Melbourne), Curtin University
-
Associate Professor, Mental Health and Addiction, Rural Health Research Institute, Charles Sturt University
-
Associate Professor and Principal Research Fellow at the Australian Research Centre in Sex, Health and Society, La Trobe University
-
Senior Lecturer in Chemistry, University of Birmingham
-
Professor of History, Shanghai University
-
Associate professor of Sociology, Huaqiao University
-
Senior lecturer, Australian National University
-
Professor of Cognitive Neuropsychology, University of Hertfordshire
-
Associate Lecturer, RMIT University
-
Honorary Clinical Professor, UCL
-
Assistant Professor, Department of Chemistry; Department of Biochemistry & Molecular Medicine; Center for Neuroscience, University of California, Davis
-
Professor of Neuropharmacology and Head of School of Pharmacy & Biomedical Sciences, University of Central Lancashire
-
Associate Professor of Anthropology; Professor of Psychiatry, Case Western Reserve University
-
PhD Candidate in Psychology + Neuroscience, University of Guelph
-
Associate Professor in Psychiatry, University of Oxford
